Here we identified a population of bone marrow neutrophils that constitutively expressed the transcription factor RORgt and produced and responded to interleukin 17A (IL-17A (IL-17)). IL-6, IL-23 and RORgt, but not T cells or natural killer (NK) cells, were required for IL-17 production in neutrophils. IL-6 and IL-23 induced expression of the receptors IL-17RC and dectin-2 on neutrophils, and IL-17RC expression was augmented by activation of dectin-2. Autocrine activity of IL-17A and its receptor induced the production of reactive oxygen species (ROS), and increased fungal killing in vitro and in a model of Aspergillusinduced keratitis. Human neutrophils also expressed RORgt and induced the expression of IL-17A, IL-17RC and dectin-2 following stimulation with IL-6 and IL-23. Our findings identify a population of human and mouse neutrophils with autocrine IL-17 activity that probably contribute to the etiology of microbial and inflammatory diseases.
A r t i c l e s Interleukin 17A (IL-17A; called 'IL-17' here) mediates the severity of autoimmune and inflammatory disease and contributes to protection against bacterial and fungal infections 1, 2 . People with impaired IL-17 responses due to the production of autoantibodies to IL-17, mutations in the gene encoding the transcription factor STAT3 or mutations in the gene encoding the type I interferon effector STAT1 that affect IL-23 production exhibit enhanced susceptibility to mucocutaneous candidiasis [3] [4] [5] [6] [7] . Although the T H 17 subset of helper T cells is considered to be the main source of IL-17, natural killer T cells (NKT cells), γδ T cells and innate lymphoid cells produce IL-17 more rapidly than do T cells because of constitutive expression of the transcription factor RORγt 8 . Neutrophils have also been identified as a source of IL-17 in human psoriatic lesions 9 and in several mouse models of infectious and autoimmune inflammation [10] [11] [12] [13] . Elevated IL-17 expression is also observed in patients with corneal ulcers caused by filamentous fungi, in which neutrophils are the predominant infiltrating cells 14 .
Here we found that human peripheral blood neutrophils and mouse bone marrow neutrophils expressed transcripts encoding IL-17A, as well as IL-17A protein, after stimulation with IL-6 and IL-23. We used reporter mice that express enhanced green fluorescent protein (GFP) under the control of the promoter of the gene encoding RORγt (Rorc GFP ) 15 to identify a population of neutrophils that constitutively expressed that transcription factor, which has until now been associated only with cells derived from the lymphoid lineage 8, 15, 16 , and found that RORγt-deficient Rorc GFP/GFP neutrophils did not produce IL-17. We also demonstrated that IL-6 and IL-23 induced expression of the receptor IL-17RC on human and mouse neutrophils, which was further increased in the presence of Aspergillus fumigatus hyphae by a pathway dependent on the C-type lectin receptor dectin-2. Finally, activation of IL-17RA-IL-17RC by endogenous or exogenous activation of IL-17 enhanced the production of reactive oxygen species (ROS), which mediated increased fungal killing in vitro and in a mouse model of corneal infection with A. fumigatus. The role of IL-17 in infection and inflammation is thought to involve the activation of fibroblasts and epithelial cells that express IL-17RA and IL-17RC to produce CXC chemokines and proinflammatory cytokines that mediate the recruitment of neutrophils and release of cytotoxic mediators such as ROS. Here we have identified a population of neutrophils that produced and used IL-17 in an autocrine manner to enhance ROS production and antifungal activity.
RESULTS

IL-17 production by neutrophils depends on IL-6 and IL-23
To determine if bone marrow neutrophils could be induced to express IL-17 in vivo, we injected C57BL/6 mice, mice deficient in recombination-activating gene 2 and the common cytokine receptor γ-chain (Rag2 −/− Il2rg −/− mice) and IL-6-deficient (Il6 −/− ) mice subcutaneously with swollen, heat-killed A. fumigatus conidia. Then, 3 d later, we examined (by flow cytometry) IL-17 production in total bone marrow cells from naive mice and from those 'primed' mice. We found that 27.8% of total bone marrow cells in naive C57BL/6 mice were Ly6G + neutrophils, as indicated by reactivity with the antibody NIMP-R14 (which detects neutrophils), and there were no cells with intracellular IL-17 (Fig. 1a) . In contrast, 6.3% of cells in 1 4 4 VOLUME 15 NUMBER 2 FEBRUARY 2014 nature immunology A r t i c l e s A. fumigatus-primed mice were IL-17 + , all of which were also NIMP-R14 + (Fig. 1a) . NIMP-R14 + bone marrow cells from primed Rag2 −/− Il2rg −/− mice, which do not have T cells or natural killer (NK) cells, were also IL-17 + after priming ( Fig. 1a) , which indicated that T cells and NK cells were not required for IL-17 production by neutrophils. CD3 + or NK1.1 + cells isolated from the spleens of C57BL/6 mice 3 d after infection with A. fumigatus did not express IL-17, although we detected CD3 + IL-17 + cells in immunized mice 10 d after subcutaneous injection (Supplementary Fig. 1a) . In contrast, we did not detect IL-17 + bone marrow cells in Il6 −/− mice (Fig. 1a) , which indicated an essential role for IL-6 in the production of IL-17 by neutrophils. To assess expression of the gene encoding IL-17 (Il17a) in bone marrow neutrophils, we also examined reporter mice that express functional IL-17 reported by GFP expression (IL-17A-GFP mice). We found that 6.7% of total bone marrow cells in IL-17A-GFP mice primed as described above were GFP + NIMP-R14 + , but those in naive IL-17A-GFP mice were not ( Fig. 1a) . Neutrophils isolated from the bone marrow of naive C57BL/6 mice by gradient centrifugation were >99% NIMP-R14 + and had a characteristic polymorphonuclear morphology (Fig. 1b) . That population was also 1A8 + CD11b + and was negative for the macrophage marker F4/80 and lymphoid cell markers ( Supplementary Fig. 1b ). Furthermore, neutrophils isolated from primed IL-17A-GFP mice contained intracellular IL-17, but those from naive IL-17A-GFP mice did not ( Fig. 1c) . We also detected individual GFP-expressing cells by confocal microscopy (Fig. 1d ) and by quantitative image analysis and flow cytometry ( Supplementary Fig. 1c ). As a second approach for assessing Il17a expression, we sorted NIMP-R14 + bone marrow cells from C57BL/6 mice by flow cytometry and analyzed gene expression by quantitative PCR. Cell-sorted neutrophils from A. fumigatusprimed mice expressed Il17a mRNA and IL-17A protein, but those from naive mice did not ( Supplementary Fig. 1d,e ).
Because IL-6, IL-23, IL-1β and transforming growth factor-β (TGF-β) mediate IL-17 expression in lymphoid cells, we examined their role in IL-17 production by neutrophils. Serum from primed C57BL/6 and Rag2 −/− Il2rg −/− mice had higher concentrations of IL-6 and IL-23 than did serum from their naive counterparts ( Fig. 1e) . Similarly, IL-6 and IL-23 (and IL-1β and TGF-β) were produced by splenocytes from naive C57BL/6 and Rag2 −/− Il2rg −/− mice after 18 h of incubation with A. fumigatus hyphal extract (AspHE) ( Fig. 1f) , which indicated that neither T cells nor NK cells were required for production of those cytokines.
To ascertain if there is a role for those cytokines in the expression of IL-17 by neutrophils, we isolated neutrophils and incubated them for 1 h with supernatants of splenocytes in the presence of neutralizing antibodies and analyzed Il17a expression by quantitative PCR. We detected PCR products of Il17a in neutrophils stimulated with supernatants of splenocytes incubated with AspHE but not in cells stimulated with supernatants of unstimulated splenocytes; furthermore, neutralization of either IL-6 or IL-23 ablated Il17a expression, whereas antibody to IL-1β (anti-IL-1β) or anti-TGF-β had no effect ( Fig. 1g ; cycling threshold scores, Supplementary Table 1 ). Together these results demonstrated that the expression of IL-17 by neutrophils 
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-/-10 6 10 5 10 4 10 3 10 2 10 1 0 10 6 10 4 10 2 0 Rag2 A r t i c l e s was dependent on IL-6 and IL-23, but not IL-1β or TGF-β, and that neither T cells nor NK cells were needed to induce IL-17 production in neutrophils.
RORgt mediates the expression of IL-17 by neutrophils
Because RORγt mediates the production of IL-17 by T H 17 cells, γδ T cells and innate lymphoid cells 8, 17, 18 , we examined its role in IL-17 production by neutrophils from homozygous Rorc GFP/GFP mice, which do not express functional RORγt 15 . We also used their heterozygous Rorc +/GFP littermates, which do express functional RORγt 15 , as controls, to detect expression of the Rorc gene and RORγt protein in neutrophils. Approximately 7% of the total GFP-expressing bone marrow cells from naive Rorc +/GFP and Rorc GFP/GFP mice were NIMP-R14 + (Fig. 2a , top), which indicated constitutive expression of Rorc in neutrophils. We also detected NIMP-R14 + GFP + cells by quantitative image analysis and flow cytometry, and Rorc mRNA was expressed in C57BL/6 neutrophils ( Supplementary Fig. 2a,b ). Intracellular staining with anti-RORγt showed that 5.6% of C57BL/6 neutrophils and 6.4% of Rorc +/GFP neutrophils were RORγt + (Fig. 2a, bottom) , which thereby demonstrated constitutive expression of RORγt in a subpopulation of neutrophils. Rorc GFP/GFP neutrophils did not express RORγt ( Fig. 2a ).
To characterize that neutrophil population further, we examined expression of receptors for IL-6 (IL-6R and gp130) and IL-23 (IL-23R and IL-12Rβ1) on bone marrow neutrophils isolated from naive A r t i c l e s IL-6 or recombinant IL-23; however, expression was higher after stimulation with the combination of IL-6 and IL-23 ( Fig. 3c) . After cells were incubated for 1 h with recombinant mouse IL-6 and IL-23, we also detected RORγt in the nucleus by confocal microscopy (Fig. 3d) .
To assess the transcriptional activity of RORγt in neutrophils stimulated with recombinant mouse IL-6 and IL-23, we examined nuclear extracts by electrophoretic mobility-shift assay with a biotinylated oligonucleotide probe that corresponds to a putative RORγt-binding region in the Il17a promoter 19 . We detected a biotinylated product in neutrophils stimulated with recombinant mouse IL-6 and IL-23, which showed a mobility shift following incubation with anti-RORγt ( Fig. 3e) . Furthermore, binding of the biotinylated probe was inhibited in the presence of a competitive, unlabeled (cold) probe, and we did not detect binding after we incubated neutrophils with a labeled (mutant) probe with three base substitutions. Together these findings demonstrated that IL-6 and IL-23 induced translocation of RORγt to the nucleus and were consistent with binding of RORγt to the Il17a promoter.
Human neutrophils express RORgt and produce IL-17
To ascertain if the combination of recombinant human IL-6 and IL-23 induced translocation of RORγt and the production of IL-17 in human neutrophils, we isolated a highly purified population of human peripheral blood neutrophils by gradient centrifugation (Supplementary Fig. 3a ) and incubated them with supernatants of human peripheral blood mononuclear cells (PBMCs) that had been stimulated for 18 h with AspHE. We detected IL-6, IL-23, IL-1β and TGF-β in supernatants from AspHE-stimulated PBMCs (Fig. 4a) . Furthermore, we detected IL17A expression in neutrophils stimulated for 1 h with supernatants from AspHE-stimulated PBMCs, although its expression was inhibited in the presence of anti-IL-6 or anti-IL-23 but not in the presence of anti-IL-1β or anti-TGF-β ( Fig. 4b and Supplementary Table 1) . C57BL/6 mice by density centrifugation. Although 26.7% bone marrow neutrophils expressed IL-6R, only 18% expressed the gp130 subunit, and 17.8% and 19.3% expressed the IL-23R and IL-12Rβ1 subunits, respectively ( Fig. 2b) . We also detected IL-6R and IL-23R on Rorc +/GFP neutrophils by flow cytometry and Il23r expression in C57BL/6 neutrophils by quantitative PCR (Supplementary Fig. 2c,d) .
To determine the role of RORγt in the production of IL-17 in neutrophils, we incubated bone marrow neutrophils from C57BL/6, Rorc +/GFP and Rorc GFP/GFP mice for 3 h with 20 µg/ml of recombinant mouse IL-6 and 2 µg/ml of recombinant mouse IL-23 (stimulation with IL-6 or IL-23 alone did not induce IL-17 mRNA expression; Supplementary Fig. 2e-g) . We did not detect intracellular IL-17 in unstimulated neutrophils from naive mice; however, C57BL/6 and Rorc +/GFP neutrophils stimulated with recombinant mouse IL-6 and IL-23 expressed IL-17, whereas we did not detect IL-17 in their Rorc GFP/GFP counterparts ( Fig. 2c,d) . Recombinant mouse IL-6 and IL-23 also induced Il17a expression in C57BL/6 and Rorc +/GFP neutrophils but not in Rorc GFP/GFP neutrophils ( Fig. 2e and Supplementary Table 1 ). Together these observations identified a population of bone marrow neutrophils that constitutively expressed RORγt and receptors for IL-6 and IL-23 and that produced IL-17 following stimulation with IL-6 and IL-23. These data also showed that IL-17 expression by neutrophils induced by recombinant mouse IL-6 and IL-23 was completely dependent on RORγt.
IL-6 and IL-23 induce translocation of RORgt to the nucleus
To examine further the role of RORγt in neutrophils, we incubated bone marrow neutrophils from naive C57BL/6 mice with splenocyte supernatants containing IL-6 and IL-23, or with recombinant IL-6 or IL-23 separately, and assessed RORγt protein in total cell lysates and in nuclear extracts by immunoblot analysis. RORγt was present in total cell lysates of unstimulated neutrophils, but we detected it in nuclear extracts only after incubation with splenocyte supernatants containing IL-6 and IL-23 (Fig. 3a,b) . We also detected RORγt in nuclear extracts that had been incubated with recombinant A r t i c l e s Consistent with those findings, we did not detect expression of the IL17A gene or IL-17 protein in unstimulated human neutrophils, whereas neutrophils stimulated with recombinant human IL-6 and IL-23 expressed IL17A mRNA ( Fig. 4c) and contained IL-17 protein in total cell lysates ( Fig. 4d) and intracellular IL-17 in ~80% of the total neutrophil population (Fig. 4e) . Stimulation with IL-6 or IL-23 alone was not sufficient to induce expression of IL17A mRNA or IL-17 protein in human neutrophils (Supplementary Fig. 3b,c) . We found that 75-77% of unstimulated peripheral blood neutrophils expressed intracellular RORγt and cell surface IL-6R and IL-23R, and those were coexpressed with intracellular IL-17 following stimulation with recombinant human IL-6 and IL-23 (Fig. 4f,g and Supplementary  Fig. 3d-g) . Together these findings demonstrated that similar to mouse neutrophils, a subset of human peripheral blood neutrophils expressed RORγt and receptors for IL-6 and IL-23, and that IL-6 and IL-23 were necessary and sufficient for IL17A expression in those cells.
IL-17RC is induced by IL-6 plus IL-23 and by dectin-2
The receptors for IL-17A and IL-17F comprise IL-17RA and IL-17RC subunits, which signal through the adaptor Act1 (refs. 20,21).
Although unstimulated human peripheral blood neutrophils express Act1 and IL-17RA 22 , neither human nor mouse neutrophils constitutively express IL-17RC 22, 23 . Consistent with those reports, we found that bone marrow neutrophils from naive C57BL/6 and Il7a −/− mice expressed Il17ra but not Il17rc (Fig. 5a) . However, Il17rc expression was elevated after 1 h incubation with recombinant mouse IL-6 and IL-23 and was further increased in the presence of AspHE but not in the presence of recombinant IL-17 ( Fig. 5a,b) . Similarly, we detected expression of IL17RC and cell surface IL-17RC by human neutrophils incubated with recombinant human IL-6 and IL-23, and the expression was further elevated by AspHE (Fig. 5c,d) . We did not detect IL-17RC in cells incubated with either IL-6 or IL-23 alone (Supplementary Fig. 4a) .
Because AspHE enhanced IL-17RC expression, we investigated whether this was mediated by the receptors dectin-1 and dectin-2, which recognize β-glucan and α-mannan, respectively, in the fungal cell wall 24, 25 . Naive C57BL/6 neutrophils expressed dectin-1 protein and its gene Clec7a, and this expression was increased by recombinant mouse IL-6 and IL-23 (Fig. 5e) . In contrast, dectin-2 protein and its gene Clec4n were not expressed in a C57BL/6 US Il17ra Il17rc Actb AspHE -
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A r t i c l e s unstimulated neutrophils but dectin-2 expression was induced at the level of RNA and cell surface protein by recombinant mouse IL-6 and IL-23 ( Fig. 5e) . Similarly, peripheral blood human neutrophils expressed only dectin-2 (encoded by CLEC6A) after incubation with recombinant human IL-6 and IL-23 ( Fig. 5f and Supplementary Fig. 4b) .
We then stimulated bone marrow neutrophils from C57BL/6, dectin-1-deficent (Clec7a −/− ) and dectin-2-deficent (Clec4n −/− ) mice with recombinant mouse IL-6 and IL-23 and AspHE, and assessed the expression of Il17rc and cell surface IL-17RC. We found that incubation with AspHE induced IL-17RC expression in C57BL/6 and Clec7a −/− neutrophils, whereas IL-17RC expression in AspHEstimulated Clec4n −/− neutrophils was not increased above that induced with recombinant mouse IL-6 and IL-23 only (Fig. 5g) . These findings demonstrated that dectin-2 mediated the increase in IL-17RC expression in response to fungal hyphae.
Neutrophils obtained from Rorc GFP/GFP mice and stimulated with recombinant mouse IL-6 and IL-23 expressed IL-17RC and dectin-2 to the same extent as did neutrophils from their Rorc +/GFP littermates (Fig. 5h,i) , which indicated that expression of those receptors was not dependent on RORγt. Rorc GFP/GFP neutrophils also expressed IL-23R (Supplementary Fig. 4c ). Finally, we found no difference in the expression of intracellular IL-17 by Clec7a −/− and Clec4n −/− neutrophils stimulated with recombinant mouse IL-6 and IL-23 and that of their C57BL/6 counterparts ( Fig. 5j) , which demonstrated that IL-17 expression was not regulated by dectin-1 or dectin-2.
Autocrine IL-17-IL-17R-mediated inhibition of fungal growth As the oxidase function of NADPH and production of ROS by neutrophils limit the growth of Aspergillus hyphae 26 , we examined the role of IL-17A and its receptor in ROS production and fungal killing. We stimulated bone marrow neutrophils from Il17a −/− and Il17rc −/− mice with recombinant mouse IL-6 and IL-23 and then incubated them with A. fumigatus hyphae. We also examined neutrophils from mice deficient in the gp91 subunit of NADPH oxidase (Cybb −/− mice, which have chronic granulomatous disease) 27 . We assessed ROS production by measuring the intracellular amount of the amine-reactive fluorescein diacetate CFDA and quantified fungal growth by fluorimetry of hyphae from an A. fumigatus strain that expresses red fluorescent protein (RFP), as described 26, 28 . To ensure that the mutations in the mice did not affect the expression of other relevant genes, we confirmed that after stimulation with recombinant mouse IL-6 and IL-23, Il17a −/− neutrophils expressed normal amounts of IL-17RC, Il17rc −/− neutrophils expressed normal amounts of IL-17, and Cybb −/− neutrophils expressed normal amounts of IL-17 and IL-17RC (Fig. 6a,b) . As reported before 26 , neutrophils from naive C57BL/6 mice produced ROS after incubation with A. fumigatus hyphae (Fig. 6c) ; however, ROS production was higher in C57BL/6 neutrophils from mice primed by subcutaneous injection of heat-killed swollen conidia (as described in Fig. 1) . ROS production was also higher in neutrophils obtained from naive mice and stimulated in vitro with recombinant mouse IL-6 and IL-23, and was not further increased following incubation with recombinant IL-17A (Fig. 6c) . In contrast, ROS production by Il17a −/− neutrophils was increased only after further stimulation with recombinant IL-17 and was blocked in the presence of anti-IL-17RC (Fig. 6c) . ROS production was not increased in Il17rc −/− neutrophils, even in the presence of recombinant IL-17A (Fig. 6c) , which demonstrated that IL-17RC expression was essential for ROS production induced by recombinant mouse IL-6 and IL-23. We did not detect ROS in Cybb −/− neutrophils stimulated with recombinant mouse IL-6 and IL-23 ( Fig. 6c and Supplementary Fig. 5) . Conversely, the fluorescence of RFP-expressing A. fumigatus (as a means of quantifying hyphal growth) was lower after incubation with C57BL/6 neutrophils alone, and hyphal growth was further inhibited by incubation with neutrophils recovered from primed or naive mice and stimulated in vitro with recombinant mouse IL-6 and IL-23 (Fig. 6c) . Il17a −/− and Il17rc −/− neutrophils stimulated with recombinant mouse IL-6 and IL-23 did not further inhibit hyphal growth; however, Il17a −/− neutrophils that were also incubated with recombinant IL-17A showed the same hyphal killing activity as that of IL-6-and IL-23-stimulated C57BL/6 neutrophils (Fig. 6c) . Hyphal growth was unimpaired following incubation with Cybb −/− neutrophils stimulated with recombinant mouse IL-6 and IL-23 (Fig. 6c) . Human peripheral blood neutrophils stimulated with recombinant human IL-6 and IL-23 had the same phenotype as that of mouse neutrophils: ROS production was increased ( Fig. 6d) A r t i c l e s inhibited (Fig. 6d) , and this was reversed by blockade of IL-17RC and was ablated in the presence of the NADPH oxidase inhibitor DPI (Fig. 6d) . Overall, these data indicated that recombinant IL-6 and IL-23-induced ROS production and fungal killing by stimulated mouse and human neutrophils was dependent on IL-17 and a functional IL-17 receptor and was mediated by NADPH oxidase.
IL-17-and IL-17R-dependent inhibition of fungal growth in vivo
To determine if IL-17-producing neutrophils regulate fungal growth in vivo, we primed C57BL/6 and IL-17A-GFP mice by subcutaneous injection of heat-killed, swollen conidia to generate IL-17producing neutrophils. After 72 h, we injected live RFP-expressing A. fumigatus conidia into the corneal stroma of the mice and, 24 h later, quantified RFP-expressing hyphae in the cornea by image analysis as described 26 . Primed, infected C57BL/6 and IL-17A-GFP mice had significantly fewer RFP hyphae than did infected mice that had not been primed (Fig. 7a,b) . Also, although there was no difference in the total number of neutrophils in infected corneas (Fig. 7c) , we detected IL-17-expressing neutrophils only in corneas of primed, infected mice (Fig. 7a,d and Supplementary Fig. 6a ).
Among neutrophils from infected corneas, IL-17-producing cells and those not producing IL-17 were 95% viable (Supplementary Fig. 6b) .
As a second approach for examining the effect of IL-17-producing neutrophils on pathogenic fungi, we used an adoptive-transfer model in which donor neutrophils are injected intravenously into recipient mice deficient in the β 2 integrin chain CD18 (Cd18 −/− mice) 26 . CD18deficient neutrophils cannot bind to the integrin α L β 2 ligand ICAM-1 on capillary endothelial cells and therefore cannot migrate into infected or inflamed tissues 29 . We stimulated bone marrow neutrophils from naive C57BL/6 and IL-17A-GFP mice for 3 h in vitro with recombinant mouse IL-6 and IL-23 and then injected them intravenously into Cd18 −/− mice, which we then infected with RFP-expressing A. fumigatus and examined as described above. Cd18 −/− mice given neutrophils stimulated with recombinant mouse IL-6 and IL-23 had significantly less RFP-expressing A. fumigatus than did mice given unstimulated neutrophils (Fig. 7e,f) , even though there was no significant difference in total neutrophils in infected corneas (Fig. 7g) . We did not detect neutrophils nor other cells in infected corneas of Cd18 −/− mice not given donor neutrophils (Supplementary Fig. 6c ). Furthermore, Cd18 −/− mice given neutrophils obtained from Il17a −/− , A r t i c l e s Il17rc −/− , Rorc GFP/GFP or Cybb −/− mice and stimulated with recombinant mouse IL-6 and IL-23 had significantly more RFP A. fumigatus than did those given neutrophils from C57BL/6 mice or the respective heterozygous littermates (Fig. 7h,i) . As there was no difference in the total number of neutrophils in infected corneas (Fig. 7j) , these data indicated the involvement of interactions between IL-17 and its receptor in enhanced fungal killing in vivo and showed that hyphal growth was dependent on ROS produced by NADPH oxidase.
DISCUSSION
Here we have presented data showing that a subpopulation of human and mouse neutrophils constitutively expressed cytoplasmic RORγt in addition to receptors for IL-6 and IL-23 and rapidly produced IL-17 and expressed functional receptors for IL-17 after stimulation with IL-6 and IL-23. Elevated Il17A expression has been reported in patients with fungal keratitis, in whom neutrophils were the predominant cells in the cornea 14 ; however, IL-17-producing neutrophils are also present in human psoriatic lesions and cutaneous T cell lymphoma lesions 9, 30 . Studies of mouse models as diverse as lipopolysaccharideinduced lung inflammation 10 , vasculitis induced by cytoplasmic autoantibodies to neutrophils 11 , acute kidney ischemia-reperfusion injury 12 , inhalation anthrax 31 , early-stage arthritis 32 , pulmonary aspergillosis 13 and systemic histoplasmosis 33 have also reported neutrophils as a source of IL-17. Further, in contrast to neutrophils from patients with psoriasis, which produce IL-17 after cell death and the formation of extracellular traps 9 , the IL-17-producing neutrophils in infected corneas in our studies were 95% viable. Although IL-23 has been linked to IL-17 production by neutrophils 12, 13, 33 , our results showed that IL-6 was required for IL-17 production in vivo. IL-6 and IL-23 were essential for expression of the gene encoding IL-17 in mouse and human neutrophils, but IL-1β and TGF-β were not. Those cytokine requirements are similar to those of natural killer cells 34 but are distinct from those of other innate lymphoid cells, including invariant NKT cells 35 , that require IL-1 and IL-23, and γδ T cells, which require IL-23 and IL-1 or IL-18, but not IL-6, for IL-17 production 36, 37 . However, given that the concentration of recombinant IL-6 and IL-23 needed to induce IL-17 expression was higher than the concentration that we detected in the serum of primed mice or in AspHE-stimulated splenocytes, it is possible that additional cytokines can mediate the production of IL-17 by neutrophils.
RORγt is expressed mainly in cells of the lymphoid lineage 8, 15, 16, 38 ; however, using transgenic mice that express GFP under control of the Rorc promoter, we demonstrated constitutive GFP expression in neutrophils and showed that RORγt was resident in the cytoplasm in unstimulated mouse and human neutrophils. We also found that RORγt translocated to the nucleus following stimulation with IL-6 and IL-23 and that it bound to oligonucleotides corresponding to the sequence of the Il17a promoter. The presence of RORγt in the cytoplasm is distinct from its location in T H 17 cells, in which it is resident in the nucleus 39 .
In addition to stimulating IL-17 production, IL-6 and IL-23 also stimulated expression of the IL-17RC subunit of the receptor in our study. As neutrophils constitutively express IL-17RA, IL-6 and IL-23 therefore induced expression of a functional receptor for IL-17 on these cells. Other studies have reported that unstimulated or lipopolysaccharide-stimulated neutrophils do not express IL-17RC and do not respond to recombinant IL-17; however, cells were not incubated with IL-6 or IL-23 in those studies 22, 23 . We found that IL-17RC expression was further elevated in the presence of fungal antigens, which was mediated by dectin-2.
The C-type lectin receptors dectin-1 and dectin-2 recognize fungal cell wall β-glucan and α-mannose, respectively 25 , and activation of dectin-2 on dendritic cells has an important role in development of T H 17 responses 24, 40 . However, although dectin-1 is expressed on unstimulated mouse and human neutrophils 26, [41] [42] [43] (as shown here), dectin-2 was expressed on neutrophils only after stimulation with recombinant mouse IL-6 and IL-23. Low expression of dectin-2 on neutrophils has been reported in a model of zymosan-induced inflammation 43 . Furthermore, although dectin-1 is activated by Aspergillus 44,45 , we found that the increased IL-17RC expression on neutrophils in the presence of those fungi was dependent on dectin-2 and not on dectin-1. The role of dectin-3, which forms heterodimers with dectin-2 on macrophages and dendritic cells 46 , is yet to be determined.
The activation of receptors for IL-17 on epithelial cells and fibro blasts stimulates the production of proinflammatory and chemotactic cytokines that mediate the recruitment of neutrophils to infected or inflamed tissues 1 . However, infiltration with the neutrophil population described here probably exacerbates the inflammatory response via the production of highly reactive oxygen radicals mediated by IL-17 and its receptor-radicals that not only have antimicrobial activity but probably also have cytotoxic and tissue-destructive activity.
Neutrophil subsets have been identified on the basis of nuclear morphology, granule protein content, cytokine production and receptor expression. For example, three neutrophil subsets are induced during infection with methicillin-resistant Staphylococcus aureus, with each subset having distinct morphology, cytokine production and antibacterial activity 47 . Also, a TGF-β-responsive subset of neutrophils has tumor-promoting activity in mice, which can be reversed by anti-TGF-β 48 . A subset of human neutrophils that express myeloid cell-associated marker Mac-1 (CD11b) and ROS has been found to inhibit the proliferation of T cells 49 , and a subset of human neutrophils that express the granule protein olfactomedin 4 has been found in inflamed joints 50 . Results from our study here have identified a subset of human and mouse neutrophils that constitutively expressed receptors for IL-6 and IL-23 on the cell surface in addition to cytoplasmic RORγt and that produced IL-17 following stimulation. Furthermore, this subset has been reported in a broad range of infectious and inflammatory conditions, which indicates that regulating the production and activity of these cells could have implications for future therapies.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. Flow cytometry. Neutrophils were incubated for 2 h at 37 °C and 5% CO 2 with a brefeldin-monensin 'cocktail' (Protein Transport Inhibitor Cocktail; eBioscience) during in vitro stimulation. Total bone marrow cells or isolated neutrophils were incubated for 15 min with antibody to mouse CD16/32 (Fc block; 93; eBioscience) or an inhibitor of binding to human Fc receptor (eBioscience), then were washed and incubated 20 min on ice with antibodies to cell surface markers ( Supplementary Table 2 ). For intracellular staining, cells were incubated 20 min in IC Fixation buffer (eBioscience), followed by permeabilization buffer (eBioscience) and 1 h of incubation with each antibody ( Supplementary  Table 2 ) in the presence of Fc block. Cells were analyzed with a FACSAria (also used for cell sorting; BD), an Image Stream (Amnis) or a C6 Accuri (BD). All gates were set on the basis of isotype-matched control antibodies.
Confocal imaging. Images were collected with the UltraVIEW VoX spinning disk confocal system (PerkinElmer) mounted on a Leica DMI6000B microscope equipped with an HCX PL APO 100× oil-immersion objective with a numerical aperture of 1.4; a step size of 0.2 µm was used. Images were then imported into Metamorph Image Analysis Software (Molecular Devices), in which maximum projections were generated from the original stacks and subjected to 'no neighbors' two-dimensional deconvolution.
Quantitative PCR. RNA was extracted from neutrophils with an RNeasy mini kit according to the manufacturer's directions (Qiagen). The quality of RNA was checked by spectrophotometry, and only samples with a ratio of 2.0 for absorbance at 260 nm relative to that at 280 were used to generate cDNA. The SuperScript First Stand synthesis system was used to generate cDNA according to manufacturer's directions (Invitrogen); primers are in Supplementary  Table 3 . An Eppendorf Master Cycle Realplex2 and SYBR Green PCR Master Mix (Applied Biosystems) were used for real-time PCR (40 cycles). The cycling threshold scores for quantitative PCR are in Supplementary Table 1 . PCR products were then separated by electrophoresis through a 1% agarose gel and were visualized by being stained with ethidium bromide.
Immunoblot analysis of cell lysates and nuclear extracts.
Neutrophils were incubated for 0, 15, 30 and 60 min with supernatants of primed or naive C57BL/6 splenocytes or with recombinant IL-6 or IL-23 or both. After treatment, cells were washed in PBS and lysed with ice-cold 1× lysis buffer (Cell Signaling Technology). Total protein was quantified by a standard bicinchoninic acid assay, then proteins were denatured with 2× Laemmli buffer (Sigma) and were heated to 95 °C for 5 min. Nuclear extracts of the cells were prepared with a nuclear extract kit as per manufacturer's directions (Pierce). Then, 10 µg of total protein was separated by 12% SDS-PAGE and transferred to nitrocellulose. Blots were probed with the following primary antibodies: anti-RORγt, anti-TBP and anti-β-actin (Supplementary Table 2 ). Horseradish peroxidase-conjugated secondary antibodies were used (Supplementary Table 2 ), and blots were developed with Supersignal West Femto Maximum Sensitivity Substrate (Pierce).
Electrophoretic mobility-shift assay.
A double-stranded-biotin labeled oligonucleotide was synthesized on the basis of DNA sequence present in the mouse Il17a promoter region containing a putative RORγt-binding site (underlined) as follows: sense, 5′-biotin-CTGTGCTGACCTCATTTGAGG-3′; antisense, 5′-biotin-CCTCAAATGAGGTCAGCACAG-3′. That sequence was derived from chromatin-immunoprecipitation analysis of transfected HEK293 human embryonic kidney cells as described 19 . As a negative control, an oligonucleotide was designed with three base substitutions (bold and underlined) in the binding region (sense, 5′-biotin-CTGTGCTTATCGCATTTGA GG-3′; antisense, 5′-biotin-CCTCAAATGCGATAAGCACAG-3′). Nuclear extracts (6 µg of protein) generated from bone marrow neutrophils were incubated for 30 min at room temperature with poly(dI:dC) and wild-type biotinylated probes.
For competition assays, nuclear extracts were preincubated for 10 min with unlabeled wild-type probes. For supershift assays, nuclear extracts were preincubated for 1 h on ice with polyclonal antibody to RORγt
